BLT again please Joe.
A small-cap biotech, genetic DNA thingies, or is that RNA/RNAI (?) Don't ask me, I'm just a shareholder.
They're just completing their cap-raising (both insto's and shareholders) today, 29th July. Shareholders' buy-in was at 0.275.
All that in combination with a share-consolidation, 25 - 1.
Trade for most of July was a temporary during-consolidation share-code of BTLDA which at present is 0.33.
August should see resumption of standard 3-letter "BLT" code.
After clinging on to life late last year, they seem to be undergoing a revival and return of confidence.
The times are good for bios. If they can convince the market that they've got a future, there's a long way up.
Thanks, and good luck all.